QUYNHLY NGUYEN: Open Payments
NPI 1063063154 · OAKLAND, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,508 in 58 payments from 14 companies in 2025. Trend: 2023 $1,766 · 2024 $2,565 · 2025 $1,508
Food & beverage: $1,409Education: $98
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $286 |
| Regeneron Healthcare Solutions, Inc. | 5 | $231 |
| ABBVIE INC. | 10 | $172 |
| Incyte Corporation | 8 | $161 |
| Lilly USA, LLC | 5 | $148 |
| Arcutis Biotherapeutics, Inc. | 2 | $138 |
| Novartis Pharmaceuticals Corporation | 4 | $103 |
| Organon LLC | 3 | $50 |
| Galderma Laboratories, L.P. | 3 | $48 |
| PFIZER INC. | 2 | $45 |
Products named: DUPIXENT, OPZELURA, TALTZ, Zoryve, SKYRIZI, RINVOQ, COSENTYX, VTAMA.
Industry payments across CA — which companies pay providers there.
